Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial.
Am J Clin Dermatol. 2022 Sep;23(5):719-728. doi: 10.1007/s40257-022-00708-w. Epub 2022 Aug 7.
Am J Clin Dermatol. 2022.
PMID: 35934770
Free PMC article.
Clinical Trial.
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours.
de Bono J, Lin CC, Chen LT, Corral J, Michalarea V, Rihawi K, Ong M, Lee JH, Hsu CH, Yang JC, Shiah HS, Yen CJ, Anthoney A, Jove M, Buschke S, Fuertig R, Schmid U, Goeldner RG, Strelkowa N, Huang DC, Bogenrieder T, Twelves C, Cheng AL.
de Bono J, et al. Among authors: buschke s.
Br J Cancer. 2020 Apr;122(9):1324-1332. doi: 10.1038/s41416-020-0774-1. Epub 2020 Mar 12.
Br J Cancer. 2020.
PMID: 32161368
Free PMC article.
Clinical Trial.
Item in Clipboard
Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjects.
Wynne C, Altendorfer M, Sonderegger I, Gheyle L, Ellis-Pegler R, Buschke S, Lang B, Assudani D, Athalye S, Czeloth N.
Wynne C, et al. Among authors: buschke s.
Expert Opin Investig Drugs. 2016 Dec;25(12):1361-1370. doi: 10.1080/13543784.2016.1255724.
Expert Opin Investig Drugs. 2016.
PMID: 27813422
Clinical Trial.
Item in Clipboard
Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment.
Schnell D, Buschke S, Fuchs H, Gansser D, Goeldner RG, Uttenreuther-Fischer M, Stopfer P, Wind S, Petersen-Sylla M, Halabi A, Koenen R.
Schnell D, et al. Among authors: buschke s.
Cancer Chemother Pharmacol. 2014 Aug;74(2):267-75. doi: 10.1007/s00280-014-2484-y. Epub 2014 Jun 7.
Cancer Chemother Pharmacol. 2014.
PMID: 24906422
Free PMC article.
Clinical Trial.
Item in Clipboard
Linagliptin fixed-dose combination with metformin is bioequivalent to co-administration of linagliptin and metformin as individual tablets.
Buschke S, Ring A, Friedrich C, Metzmann K, Meinicke T.
Buschke S, et al.
Int J Clin Pharmacol Ther. 2014 Jul;52(7):537-48. doi: 10.5414/CP201960.
Int J Clin Pharmacol Ther. 2014.
PMID: 24755123
Clinical Trial.
Item in Clipboard
A decisive function of transforming growth factor-β/Smad signaling in tissue morphogenesis and differentiation of human HaCaT keratinocytes.
Buschke S, Stark HJ, Cerezo A, Prätzel-Wunder S, Boehnke K, Kollar J, Langbein L, Heldin CH, Boukamp P.
Buschke S, et al.
Mol Biol Cell. 2011 Mar 15;22(6):782-94. doi: 10.1091/mbc.E10-11-0879. Epub 2011 Feb 2.
Mol Biol Cell. 2011.
PMID: 21289094
Free PMC article.
Item in Clipboard
Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome.
Hamacher J, Lucas R, Lijnen HR, Buschke S, Dunant Y, Wendel A, Grau GE, Suter PM, Ricou B.
Hamacher J, et al. Among authors: buschke s.
Am J Respir Crit Care Med. 2002 Sep 1;166(5):651-6. doi: 10.1164/rccm.2109004.
Am J Respir Crit Care Med. 2002.
PMID: 12204860
Item in Clipboard
Cite
Cite